Clair Health Secures $11M for Noninvasive Hormone Tracker
Clair Health, a company founded by two Stanford graduates, has successfully raised $11 million in funding. This capital is earmarked for the development of a noninvasive wearable device designed for hormone tracking. The forthcoming wearable is projected to retail for $369, accompanied by a monthly app-based subscription fee of $9.99.
Clair Health, a company spearheaded by two Stanford graduates, has reportedly secured $11 million in funding. This financial backing is designated for the creation of a noninvasive wearable device focused on hormone tracking.
The upcoming wearable product from Clair Health is expected to be priced at $369. In addition to the device cost, an app-based subscription will be available for $9.99 per month.
According to TechCrunch, these details highlight Clair Health's recent funding and product pricing structure.
